(Q44214952)
Statements
Inhibition of human telomerase enhances the effect of the tyrosine kinase inhibitor, imatinib, in BCR-ABL-positive leukemia cells (English)
Kazuma Ohyashiki
1 reference
Tetsuzo Tauchi
Akihiro Nakajima
Goro Sashida
Takashi Shimamoto
Junko H Ohyashiki
Kenji Abe
Kohtaro Yamamoto
Kazuma Ohyashiki
1 November 2002